Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
003017 Zhejiang Dayang Biotech Group
- 20.56
- +0.41+2.03%
Market Closed Dec 20 15:00 CST
1.73BMarket Cap28.28P/E (TTM)
20.78High20.14Low11.75KlotVolume20.14Open20.15Pre Close24.12MTurnover1.74%Turnover Ratio34.55P/E (Static)84.00MShares24.8652wk High1.68P/B1.39BFloat Cap11.4752wk Low22.17Limit Up67.59MShs Float42.94Historical High18.14Limit Down3.18%Amplitude11.47Historical Low0.45Dividend TTM20.52Avg Price5.57KlotAsk2.19%Div YieldTTM100Lot Size6.04KlotBid
Zhejiang Dayang Biotech Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.01%671.79M | -9.23%437.22M | -22.46%194.84M | -13.10%919.45M | -2.78%714.74M | -2.23%481.67M | 29.50%251.29M | 35.10%1.06B | 29.49%735.17M | 27.65%492.64M |
| Operating revenue | -6.01%671.79M | -9.23%437.22M | -22.46%194.84M | -13.10%919.45M | -2.78%714.74M | -2.23%481.67M | 29.50%251.29M | 35.10%1.06B | 29.49%735.17M | 27.65%492.64M |
| Other operating revenue | ---- | 4.93%4.38M | ---- | -30.82%7.22M | ---- | -6.29%4.18M | ---- | -2.52%10.43M | ---- | -2.63%4.46M |
| Total operating cost | -8.99%627.41M | -11.56%411.7M | -23.06%179.8M | -14.49%874.48M | -2.41%689.42M | -1.38%465.5M | 21.58%233.68M | 39.80%1.02B | 38.28%706.45M | 37.39%472.03M |
| Operating cost | -8.76%543.82M | -11.79%354.05M | -23.38%157.39M | -17.40%753.18M | -5.45%596.05M | -3.60%401.35M | 21.07%205.43M | 44.50%911.85M | 41.88%630.4M | 38.62%416.34M |
| Operating tax surcharges | -2.39%5.43M | -11.18%3.39M | -39.81%1.38M | 0.85%7.32M | 27.43%5.56M | 19.08%3.82M | 63.92%2.29M | 33.21%7.26M | 13.56%4.36M | 18.61%3.21M |
| Operating expense | -12.10%6.32M | -2.44%4.4M | -12.64%1.74M | 11.22%9.82M | 28.12%7.19M | 20.46%4.51M | 33.93%1.99M | 18.24%8.83M | 12.43%5.61M | 9.12%3.75M |
| Administration expense | -1.39%50.42M | -3.05%34.63M | 6.64%14.44M | 14.26%67.06M | 32.18%51.14M | 32.17%35.72M | 14.05%13.54M | 3.69%58.69M | 5.76%38.69M | 7.53%27.02M |
| Financial expense | 94.49%-81.33K | -928.35%-963.61K | -191.76%-1.77M | -206.30%-2.12M | -246.46%-1.48M | -116.17%-93.7K | 63.01%1.93M | -35.97%2M | -65.13%1.01M | -69.20%579.36K |
| -Interest expense (Financial expense) | 60.55%5.66M | 39.92%4.08M | -35.11%1.1M | 12.13%6.14M | -35.92%3.52M | -0.03%2.91M | 65.15%1.7M | 97.54%5.48M | 86.92%5.5M | 70.67%2.91M |
| -Interest Income (Financial expense) | -36.94%-6.41M | -100.36%-4.33M | -384.01%-2.47M | -494.60%-7.67M | -483.77%-4.68M | -423.30%-2.16M | -385.55%-510.68K | -124.10%-1.29M | -83.80%-801.86K | -40.10%-413.01K |
| Research and development | -30.56%21.5M | -19.79%16.2M | -22.05%6.63M | 15.13%39.22M | 17.37%30.96M | -4.45%20.2M | 28.89%8.5M | 22.36%34.06M | 44.45%26.38M | 109.99%21.14M |
| Credit Impairment Loss | -421.63%-1.73M | -452.56%-1.65M | -179.17%-1.46M | 194.02%1.54M | 47.25%-332.16K | 200.16%467.59K | -5.82%-523.39K | -1,371.49%-1.64M | -701.30%-629.66K | -1,658.80%-466.85K |
| Asset Impairment Loss | 19.89%-1.82M | 46.65%-1.68M | 73.86%-306.82K | -6,271.65%-11.55M | -914.15%-2.27M | -1,874.45%-3.16M | ---1.17M | 87.78%-181.19K | ---223.41K | --177.85K |
| Other net revenue | -31.18%10.02M | -40.59%4.05M | -29.08%2.85M | -52.42%11.32M | -9.69%14.56M | -35.98%6.82M | -47.44%4.01M | -13.96%23.79M | -30.89%16.12M | -41.81%10.65M |
| Fair value change income | 116.78%248.01K | ---- | ---- | -307.37%-1.48M | 5.47%-1.48M | -2.75%-883.79K | 35.98%1.33M | 324.61%712.58K | -349.93%-1.56M | -210.07%-860.16K |
| Invest income | -136.63%-1.35M | -126.33%-658.99K | -171.88%-853.91K | 41.61%3.12M | 15.51%3.69M | 15.02%2.5M | -22.90%1.19M | -79.30%2.2M | -63.54%3.19M | -65.77%2.18M |
| -Including: Investment income associates | ---- | -353.53%-349.07K | ---- | -3,355.42%-553.96K | -1,622.45%-238.25K | -482.94%-76.97K | ---- | 79.74%-16.03K | -121.94%-13.83K | -120.73%-13.2K |
| Asset deal income | 101.56%3.84K | -93.45%3.84K | -94.03%3.84K | -105.00%-170.68K | -179.03%-245.51K | -68.31%58.6K | -65.18%64.37K | 2,635.74%3.41M | 0.40%310.67K | 86.59%184.89K |
| Other revenue | -3.49%14.66M | 2.67%8.04M | 74.47%5.46M | 3.00%19.85M | 1.05%15.19M | -17.05%7.83M | -42.32%3.13M | 3.93%19.27M | 9.61%15.04M | -14.47%9.44M |
| Operating profit | 36.40%54.4M | 28.64%29.56M | -17.26%17.89M | -4.90%56.29M | -11.06%39.88M | -26.47%22.98M | 128.17%21.62M | -25.38%59.19M | -44.08%44.84M | -48.46%31.26M |
| Add:Non operating Income | -43.84%101.88K | 14.51%65.61K | -76.75%23.38K | -65.07%92.1K | -3.16%181.4K | -62.35%57.3K | 1,549.58%100.57K | -33.64%263.66K | 37.06%187.33K | 257.45%152.17K |
| Less:Non operating expense | -73.93%324.45K | -83.47%53.58K | -87.35%29.59K | 369.15%9.4M | 13.45%1.24M | -2.40%324.24K | 26.03%233.99K | -44.12%2M | -22.41%1.1M | -12.35%332.2K |
| Total profit | 39.57%54.18M | 30.21%29.58M | -16.78%17.89M | -18.22%46.99M | -11.64%38.82M | -26.91%22.72M | 131.14%21.49M | -24.54%57.45M | -44.32%43.93M | -48.48%31.08M |
| Less:Income tax cost | 314.15%2.91M | -62.81%-1.86M | -53.82%967.19K | 87.02%-3.02M | 77.97%-1.36M | 81.77%-1.14M | 141.67%2.09M | -479.70%-23.27M | -165.51%-6.17M | -180.53%-6.27M |
| Net profit | 27.60%51.27M | 31.77%31.44M | -12.78%16.92M | -38.05%50.01M | -19.81%40.18M | -36.11%23.86M | 130.06%19.4M | 15.31%80.73M | -27.90%50.1M | -28.92%37.34M |
| Net profit from continuing operation | 27.60%51.27M | 31.77%31.44M | -12.78%16.92M | -38.05%50.01M | -19.81%40.18M | -36.11%23.86M | 130.06%19.4M | 15.31%80.73M | -27.90%50.1M | -28.92%37.34M |
| Net profit of parent company owners | 27.60%51.27M | 31.77%31.44M | -12.78%16.92M | -38.05%50.01M | -19.81%40.18M | -36.11%23.86M | 130.06%19.4M | 15.31%80.73M | -27.90%50.1M | -28.92%37.34M |
| Earning per share | ||||||||||
| Basic earning per share | 26.53%0.62 | -5.97%0.3857 | -38.24%0.21 | -55.35%0.6194 | -41.67%0.49 | -34.98%0.4102 | 142.86%0.34 | 18.89%1.3872 | -27.59%0.84 | -28.31%0.6309 |
| Diluted earning per share | 26.53%0.62 | -5.97%0.3857 | -38.24%0.21 | -55.31%0.6194 | -41.67%0.49 | -34.98%0.4102 | 142.86%0.34 | 18.79%1.386 | -27.59%0.84 | -28.31%0.6309 |
| Other composite income | ||||||||||
| Total composite income | 27.60%51.27M | 31.77%31.44M | -12.78%16.92M | -38.05%50.01M | -19.81%40.18M | -36.11%23.86M | 130.06%19.4M | 15.31%80.73M | -27.90%50.1M | -28.92%37.34M |
| Total composite income of parent company owners | 27.60%51.27M | 31.77%31.44M | -12.78%16.92M | -38.05%50.01M | -19.81%40.18M | -36.11%23.86M | 130.06%19.4M | 15.31%80.73M | -27.90%50.1M | -28.92%37.34M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.